Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
AMGEN Inc's new cholesterol drug is still struggling to gain traction, missing analysts' estimates at a time when the biotechnology giant is anxious for its newer drugs to make up for slowing sales of its older ones.
Sales of the drug, called Repatha, for the first